SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.11-2.6%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject8/24/2003 12:12:46 AM
From: Ian@SI  Read Replies (2) of 52153
 
Barron's Interview with fund manager Wesbrod's discusses several biotechs and gives an honourable mention to MLNM.

Rescued by Biotech
Health-care investor chalks up a 43% gain in a comeback performance

By BILL ALPERT

An Interview With Stuart Weisbrod - He has achieved more-than-respectable returns in the five years since he started the investing firm Merlin BioMed Group in Manhattan. With a team of doctors and financial analysts, Weisbrod focuses on biotech, drugs and medical devices. He's certainly ridden the year's riot in biotech, but Weisbrod insists that opportunities persist in the health-care sector. To discover where, read on.
[snip]

His picks and pans.


Weisbrod's Picks and Pans
Picks
Company            Ticker    Recent Price
Genzyme General    GENZ      $46.53
Repligen           RGEN        6.88
Celgene            CELG       38.78
GlaxoSmithKline    GSK        38.43
Roche              RHHBY      79.50
Teva Pharmaceutical TEVA      58.38
Stada Arzneimittel G.STD     €50.77
Edwards Lifesciences EW       28.36
Smith & Nephew     SNN        62.69

And Pans
Express Scripts    ESRX      $63.48
Biogen             BGEN       37.31


Whole story at: online.wsj.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News